Stem cell use for cardiac diseases as of 2008

Transfusion and Apheresis Science

Volumn 38, Issue 3, 2008, Pages 253-260

  Ortak, Jasmin ^a   Akin, Ibrahim ^a   Kische, Stephan ^a   Nienaber, Christoph A ^a   Ince, Hüseyin ^a  

^a ROSTOCK UNIVERSITY MEDICAL CENTER   (Germany)

Author keywords

Bone marrow derived mononuclear cells; Embryonic stem cells; G CSF; Heart failure; Myoblasts

Indexed keywords

GRANULOCYTE COLONY STIMULATING FACTOR;

ACUTE HEART INFARCTION; ARTICLE; CD34 SELECTION; CELL SURVIVAL; CELL THERAPY; CONGESTIVE HEART FAILURE; EMBRYONIC STEM CELL; ENDOTHELIUM CELL; ETHICS; HUMAN; MESENCHYMAL STEM CELL; MONONUCLEAR CELL; MORBIDITY; MORTALITY; MYOBLAST; STEM CELL TRANSPLANTATION; TISSUE REGENERATION;

CORONARY ARTERY DISEASE; HEART FAILURE; HUMANS; STEM CELL TRANSPLANTATION; STEM CELLS;

EID: 44949217355     PISSN: 14730502     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.transci.2008.04.003     Document Type: Article

References (61)

1. Kehat I., Khimovich L., Caspi O., Gepstein A., Shofti R., Arbel G., et al. Electromechanical integration of cardiomyocytes derived from human embryonic stem cells. Nat Biotechnol 22 10 (2004) 1282-1289
2. Li Z., Wu J.C., Sheikh A.Y., Kraft D., Cao F., Xie X., et al. Differentiation, survival, and function of embryonic stem cell derived endothelial cells for ischemic heart disease. Circulation 116 Suppl. 11 (2007) I46-I54
3. Yamashita J., Itoh H., Hirashima M., Ogawa M., Nishikawa S., Yurugi T., et al. Flk1-positive cells derived from embryonic stem cells serve as vascular progenitors. Nature 408 6808 (2000) 92-96
4. Laflamme M.A., Chen K.Y., Naumova A.V., Muskheli V., Fugate J.A., Dupras S.K., et al. Cardiomyocytes derived from human embryonic stem cells in pro-survival factors enhance function of infarcted rat hearts. Nat Biotechnol 25 9 (2007) 1015-1024
5. Singla D.K., Hacker T.A., Ma L., Douglas P.S., Sullivan R., Lyons G.E., et al. Transplantation of embryonic stem cells into the infarcted mouse heart: formation of multiple cell types. J Mol Cell Cardiol 40 1 (2006) 195-200
6. Leor J., Gerecht S., Cohen S., Miller L., Holbova R., Ziskind A., et al. Human embryonic stem cell transplantation to repair the infarcted myocardium. Heart 93 10 (2007) 1278-1284
7. Pagani F.D., DerSimonian H., Zawadzka A., Wetzel K., Edge A.S., Jacoby D.B., et al. Autologous skeletal myoblasts transplanted to ischemia-damaged myocardium in humans. Histological analysis of cell survival and differentiation. J Am Coll Cardiol 41 5 (2003) 879-888
8. Taylor D.A., Atkins B.Z., Hungspreugs P., Jones T.R., Reedy M.C., Hutcheson K.A., et al. Regenerating functional myocardium: improved performance after skeletal myoblast transplantation. Nat Med 4 8 (1998) 929-933
9. Hagege A.A., Carrion C., Menasche P., Vilquin J.T., Duboc D., Marolleau J.P., et al. Viability and differentiation of autologous skeletal myoblast grafts in ischaemic cardiomyopathy. Lancet 361 9356 (2003) 491-492
10. Menasche P., Hagege A.A., Vilquin J.T., Desnos M., Abergel E., Pouzet B., et al. Autologous skeletal myoblast transplantation for severe post-infarction left ventricular dysfunction. J Am Coll Cardiol 41 7 (2003) 1078-1083
11. Menasche P. Skeletal myoblasts as a therapeutic agent. Prog Cardiovasc Dis 50 1 (2007) 7-17
12. Chazaud B., Sonnet C., Lafuste P., Bassez G., Rimaniol A.C., Poron F., et al. Satellite cells attract monocytes and use macrophages as a support to escape apoptosis and enhance muscle growth. J Cell Biol 163 5 (2003) 1133-1143
13. Gnecchi M., He H., Liang O.D., Melo L.G., Morello F., Mu H., et al. Paracrine action accounts for marked protection of ischemic heart by Akt-modified mesenchymal stem cells. Nat Med 11 4 (2005) 367-368
14. Siminiak T., Fiszer D., Jerzykowska O., Grygielska B., Rozwadowska N., Kalmucki P., et al. Percutaneous trans-coronary-venous transplantation of autologous skeletal myoblasts in the treatment of post-infarction myocardial contractility impairment: the POZNAN trial. Eur Heart J 26 12 (2005) 1188-1195
15. Dib N., Michler R.E., Pagani F.D., Wright S., Kereiakes D.J., Lengerich R., et al. Safety and feasibility of autologous myoblast transplantation in patients with ischemic cardiomyopathy: four-year follow-up. Circulation 112 12 (2005) 1748-1755
16. Herreros J., Prosper F., Perez A., Gavira J.J., Garcia-Velloso M.J., Barba J., et al. Autologous intramyocardial injection of cultured skeletal muscle-derived stem cells in patients with non-acute myocardial infarction. Eur Heart J 24 22 (2003) 2012-2020
17. Ince H., Petzsch M., Rehders T.C., Chatterjee T., and Nienaber C.A. Transcatheter transplantation of autologous skeletal myoblasts in post-infarction patients with severe left ventricular dysfunction. J Endovasc Ther 11 6 (2004) 695-704
18. Smits P.C., van Geuns R.J., Poldermans D., Bountioukos M., Onderwater E.E., Lee C.H., et al. Catheter-based intramyocardial injection of autologous skeletal myoblasts as a primary treatment of ischemic heart failure: clinical experience with six-month follow-up. J Am Coll Cardiol 42 12 (2003) 2063-2069
19. Menasche P. The MAGIC trial. In: Fourth international symposium on stem cell therapy and applied cardiovascular biology, Madrid, Spain; April 26th-27th 2007.
20. Schachinger V., Assmus B., Britten M.B., Honold J., Lehmann R., Teupe C., et al. Transplantation of progenitor cells and regeneration enhancement in acute myocardial infarction: final one-year results of the TOPCARE-AMI trial. J Am Coll Cardiol 44 8 (2004) 1690-1699
21. Strauer B.E., Brehm M., Zeus T., Bartsch T., Schannwell C., Antke C., et al. Regeneration of human infarcted heart muscle by intracoronary autologous bone marrow cell transplantation in chronic coronary artery disease: the IACT study. J Am Coll Cardiol 46 9 (2005) 1651-1658
22. Wollert K.C., Meyer G.P., Lotz J., Ringes-Lichtenberg S., Lippolt P., Breidenbach C., et al. Intracoronary autologous bone-marrow cell transfer after myocardial infarction: the BOOST randomised controlled clinical trial. Lancet 364 9429 (2004) 141-148
23. Meyer G.P., Wollert K.C., Lotz J., Steffens J., Lippolt P., Fichtner S., et al. Intracoronary bone marrow cell transfer after myocardial infarction: eighteen months' follow-up data from the randomized, controlled BOOST (BOne marrOw transfer to enhance ST-elevation infarct regeneration) trial. Circulation 113 10 (2006) 1287-1294
24. Dohmann H.F., Perin E.C., Takiya C.M., Silva G.V., Silva S.A., Sousa A.L., et al. Transendocardial autologous bone marrow mononuclear cell injection in ischemic heart failure: postmortem anatomicopathologic and immunohistochemical findings. Circulation 112 4 (2005) 521-526
25. Schachinger V., Erbs S., Elsasser A., Haberbosch W., Hambrecht R., Holschermann H., et al. REPAIR-AMI investigators. Intracoronary bone marrow-derived progenitor cells in acute myocardial infarction. N Engl J Med 355 12 (2006) 1210-1221
26. Janssens S., Dubois C., Bogaert J., Theunissen K., Deroose C., Desmet W., et al. Autologous bone marrow-derived stem-cell transfer in patients with ST-segment elevation myocardial infarction: double-blind, randomised controlled trial. Lancet 367 9505 (2006) 113-121
27. Lunde K., Solheim S., Aakhus S., Arnesen H., Abdelnoor M., Egeland T., et al. Intracoronary injection of mononuclear bone marrow cells in acute myocardial infarction. N Engl J Med 355 12 (2006) 1199-1209
28. Seeger F.H., Tonn T., Krzossok N., Zeiher A.M., and Dimmeler S. Cell isolation procedures matter: a comparison of different isolation protocols of bone marrow mononuclear cells used for cell therapy in patients with acute myocardial infarction. Eur Heart J 28 6 (2007) 766-772
29. Lunde K., Solheim S., Aakhus S., Arnesen H., Abdelnoor M., and Forfang K. ASTAMI investigators. Autologous stem cell transplantation in acute myocardial infarction: the ASTAMI randomized controlled trial. Intracoronary transplantation of autologous mononuclear bone marrow cells, study design and safety aspects. Scand Cardiovasc J 39 3 (2005) 150-158
30. De Falco E., Porcelli D., Torella A.R., Straino S., Iachininoto M.G., Orlandi A., et al. SDF-1 involvement in endothelial phenotype and ischemia-induced recruitment of bone marrow progenitor cells. Blood 104 12 (2004) 3472-3482
31. Schachinger V., Tonn T., Dimmeler S., and Zeiher A.M. Bone-marrow-derived progenitor cell therapy in need of proof of concept: design of the REPAIR-AMI trial. Nat Clin Pract Cardiovasc Med 3 Suppl. 1 (2006) S23-S28
32. Yin A.H., Miraglia S., Zanjani E.D., Almeida-Porada G., Ogawa M., Leary A.G., et al. AC133, a novel marker for human hematopoietic stem and progenitor cells. Blood 90 12 (1997) 5002-5012
33. Eichmann A., Corbel C., Nataf V., Vaigot P., Breant C., and Le Douarin N.M. Ligand-dependent development of the endothelial and hemopoietic lineages from embryonic mesodermal cells expressing vascular endothelial growth factor receptor 2. Proc Natl Acad Sci USA 94 10 (1997) 5141-5146
34. Kocher A.A., Schuster M.D., Szabolcs M.J., Takuma S., Burkhoff D., Wang J., et al. Neovascularization of ischemic myocardium by human bone-marrow-derived angioblasts prevents cardiomyocyte apoptosis, reduces remodeling and improves cardiac function. Nat Med 7 4 (2001) 430-436
35. Schuster M.D., Kocher A.A., Seki T., Martens T.P., Xiang G., Homma S., et al. Myocardial neovascularization by bone marrow angioblasts results in cardiomyocyte regeneration. Am J Physiol Heart Circ Physiol 287 2 (2004) H525-H532
36. Erbs S., Linke A., Adams V., Lenk K., Thiele H., Diederich K.W., et al. Transplantation of blood-derived progenitor cells after recanalization of chronic coronary artery occlusion: first randomized and placebo-controlled study. Circ Res 97 8 (2005) 756-762
37. Picinich S.C., Mishra P.J., Mishra P.J., Glod J., and Banerjee D. The therapeutic potential of mesenchymal stem cells. Cell- & tissue-based therapy. Expert Opin Biol Ther 7 7 (2007) 965-973
38. Zimmet J.M., and Hare J.M. Emerging role for bone marrow derived mesenchymal stem cells in myocardial regenerative therapy. Basic Res Cardiol 100 6 (2005) 471-481
39. Amado L.C., Saliaris A.P., Schuleri K.H., St John M., Xie J.S., Cattaneo S., et al. Cardiac repair with intramyocardial injection of allogeneic mesenchymal stem cells after myocardial infarction. Proc Natl Acad Sci USA 102 32 (2005) 11474-11479
40. Mazhari R., and Hare J.M. Mechanisms of action of mesenchymal stem cells in cardiac repair: potential influences on the cardiac stem cell niche. Nat Clin Pract Cardiovasc Med 4 Suppl. 1 (2007) S21-S26
41. Mangi A.A., Noiseux N., Kong D., He H., Rezvani M., Ingwall J.S., et al. Mesenchymal stem cells modified with Akt prevent remodeling and restore performance of infarcted hearts. Nat Med 9 9 (2003) 1195-1201
42. Davis M.E., Hsieh P.C., Takahashi T., Song Q., Zhang S., Kamm R.D., et al. Local myocardial insulin-like growth factor 1 (IGF-1) delivery with biotinylated peptide nanofibers improves cell therapy for myocardial infarction. Proc Natl Acad Sci USA 103 21 (2006) 8155-8160
43. Chen S.L., Fang W.W., Ye F., Liu Y.H., Qian J., Shan S.J., et al. Effect on left ventricular function of intracoronary transplantation of autologous bone marrow mesenchymal stem cell in patients with acute myocardial infarction. Am J Cardiol 94 1 (2004) 92-95
44. Urbanek K., Torella D., Sheikh F., De Angelis A., Nurzynska D., Silvestri F., et al. Myocardial regeneration by activation of multipotent cardiac stem cells in ischemic heart failure. Proc Natl Acad Sci USA 102 24 (2005) 8692-8697
45. Leri A., Kajstura J., and Anversa P. Cardiac stem cells and mechanisms of myocardial regeneration. Physiol Rev 85 4 (2005) 1373-1416
46. Bearzi C., Rota M., Hosoda T., Tillmanns J., Nascimbene A., De Angelis A., et al. Human cardiac stem cells. Proc Natl Acad Sci USA 104 35 (2007) 14068-14073
47. + progenitor cells lead to cardiac, smooth muscle, and endothelial cell diversification. Cell 127 6 (2006) 1151-1165
48. Anversa P., Leri A., Rota M., Hosoda T., Bearzi C., Urbanek K., et al. Concise review: stem cells, myocardial regeneration, and methodological artifacts. Stem Cells 25 3 (2007) 589-601
49. + cell proliferation and differentiation. Circ Res 97 8 (2005) e73-e83
50. Smith R.R., Barile L., Cho H.C., Leppo M.K., Hare J.M., Messina E., et al. Regenerative potential of cardiosphere-derived cells expanded from percutaneous endomyocardial biopsy specimens. Circulation 115 7 (2007) 896-908
51. Ince H., Petzsch M., Kleine H.D., Eckard H., Rehders T., Burska D., et al. Prevention of left ventricular remodeling with G-CSF after acute myocardial infarction: final one-year results of the FIRSTLINE-AMI trial (front-integrated revascularization and stem cell liberation in evolving acute myocardial infarction by granulocyte colony-stimulating factor). Circulation 112 Suppl. 9 (2005) 173-180
52. Shintani S., Murohara T., Ikeda H., Ueno T., Honma T., Katoh A., et al. Mobilization of endothelial progenitor cells in patients with acute myocardial infarction. Circulation 103 (2001) 2776-2779
53. + stem cells, and mononuclear cells expressing early cardiac, muscle, and endothelial markers into peripheral blood in patients with acute myocardial infarction. Circulation 110 (2004) 3213-3220
54. Leone A.M., Rutella S., Bonanno G., Abbate A., Rebuzzi A.G., Giovannini S., et al. Mobilization of bone marrow derived stem cells after myocardial infarction and left ventricular function. Eur Heart J 26 (2005) 1196-1204
55. + and endothelial progenitor cells in patients with various degrees of congestive heart failure. Circulation 110 (2004) 1209-1212
56. + cell mobilization after acute myocardial infarction. Int J Cardiol 111 2 (2005) 202-208
57. Ince H., Petzsch M., Kleine H.D., Schmidt H., Rehders T., Körber T., et al. Preservation from left ventricular remodeling by front-integrated revascularization and stem cell liberation in evolving acute myocardial infarction using granulocyte colony stimulating factor (FIRSTLINE-AMI). Circulation 112 20 (2005) 3097-3106
58. Zohlnhofer D., Ott I., Mehilli J., Schomig K., Michalk F., Ibrahim T., et al. REVIVAL-2 Investigators Stem cell mobilization by granulocyte colony-stimulating factor in patients with acute myocardial infarction, a randomized controlled trial. JAMA 295 9 (2006) 1003-1010
59. Harada M., Qin Y., Takano H., Minamino T., Zou Y., Toko H., et al. G-CSF prevents cardiac remodeling after myocardial infarction by activating the Jak-Stat pathway in cardiomyocytes. Nat Med 11 3 (2005) 305-311
60. Beohar N., Flaherty J.D., Davidson C.J., Vidovich M., Singhal S., Rapp J.A., et al. Granulocyte-colony stimulating factor administration after myocardial infarction in a porcine ischemia-reperfusion model: functional and pathological effects of dose timing. Catheter Cardiovasc Interv 69 2 (2007) 257-266
61. Lehrke S., Mazhari R., Durand D.J., Zheng M., Bedja D., Zimmet J.M., et al. Aging impairs the beneficial effect of granulocyte colony-stimulating factor and stem cell factor on post-myocardial infarction remodeling. Circ Res 99 5 (2006) 553-560